BL
GSK icon

BFSG LLC’s GSK GSK Stock Holding History

BFSG LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11K Hold
200
– – ﹤0.01% 552
2025
Q4 		$9.81K Buy
+200
New +$9.33K ﹤0.01% 546
2021
Q2 		– Sell
-28,282
Closed -$1.26M – 160
2021
Q1 		$1.26M Sell
28,282
-1,640
-5% -$74.4K 0.2% 113
2020
Q4 		$1.38M Sell
29,922
-571
-2% -$26.2K 0.23% 103
2020
Q3 		$1.44M Sell
30,493
-32
-0.1% -$1.6K 0.27% 92
2020
Q2 		$1.56M Hold
30,525
– – 0.34% 82
2020
Q1 		$1.45M Sell
30,525
-1,388
-4% -$74K 0.37% 81
2019
Q4 		$1.87M Sell
31,913
-80
-0.3% -$4.45K 0.35% 84
2019
Q3 		$1.65M Buy
+31,993
New +$1.65M 0.37% 80

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFSG LLC's GSK Position: Q1 2026 in Review

BFSG LLC held its GSK (GSK) position steady in Q1 2026 at 200 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #552.

BFSG LLC first reported a position in GSK in Q3 2019 and has held it in 9 quarters since. The position peaked at $1.87M in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • BFSG LLC held 200 shares of GSK worth $11K as of Q1 2026.
  • BFSG LLC left its GSK share count unchanged in Q1 2026.
  • GSK made up ﹤0.01% of BFSG LLC's portfolio in Q1 2026, its #552 holding.
  • BFSG LLC first reported a position in GSK in Q3 2019 and has held it in 9 quarters since.
  • BFSG LLC's GSK position peaked at $1.87M in Q4 2019.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on BFSG LLC's 13F filing for Q1 2026, filed 29 Apr 2026.